Expertise in
51
conditions

Dr. Andrew F. Trainer

Urology
Adult & Pediatric Urology PC
10707 Pacific St Ste 101, 
Omaha, NE 
Accepting New Patients
Expertise in
51
conditions
Adult & Pediatric Urology PC
10707 Pacific St Ste 101, 
Omaha, NE 

Overview

Andrew Trainer is a Urologist practicing medicine in Omaha, Nebraska.

Dr. Trainer is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Aquablation, and Prostatectomy.

He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 10 clinical trials. Dr. Trainer is currently accepting new patients.

Specialties

Urology

Licenses

Urology in NE

Hospital Affiliations

The Nebraska Methodist Hospital
Chi Health Lakeside
Myrtue Medical Center
Boys Town National Research Hospital
Methodist Jennie Edmundson

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 16 Less Insurance Carriers -

Locations

Adult & Pediatric Urology PC
10707 Pacific St Ste 101, Omaha, NE 68114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

ROBUST III - Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease - A Randomized Control Trial
ROBUST III - Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease - A Randomized Control Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 19, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 31, 2026
Intervention Type: Biological
Study Drugs: Bacillus of Calmette-Guerin, ALT-803
Study Phase: Phase 1/Phase 2
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: ALT-803, Bacillus Calumette-Guerin
Study Phase: Phase 2/Phase 3
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Biological
Study Drugs: Aglatimagene besadenovec, Valacyclovir
Study Phase: Phase 3
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug, Procedure
Study Drug: Mitomycin C
Study Phase: Phase 3
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Open-Label Extension Clinical Trial of the Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED)
A Randomized, Double-Blind, Placebo-Controlled, Open-Label Extension Clinical Trial of the Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED)
Enrollment Status: Terminated
Publish Date: August 17, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

22 Total Publications

Reply by Authors.
Reply by Authors.
Journal: The Journal of urology
Published: August 24, 2026
Similar Doctors
Expertise in
48
conditions
Expertise in
48
conditions
Referral may be required

Adult & Pediatric Urology PC

10707 Pacific St Ste 101, 
Omaha, NE 
 (0.1 miles away)
402-397-7989
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Arther is a Urologist practicing medicine in Omaha, Nebraska. Dr. Arther is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Kidney Stones, UPJ Obstruction, Aquablation, and Reconstructive Urology Surgery. Dr. Arther is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Urology Clinic At Lauritzen Outpatient Center

4014 Leavenworth St., 
Omaha, NE 
 (5.5 miles away)
402-559-4292
Languages Spoken:
English, American Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Deibert is a Urologist practicing medicine in Omaha, Nebraska. Dr. Deibert is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Eunuchoidism Familial Hypogonadotropic, Kidney Stones, Prostate Cancer, Vasectomy, and Prostatectomy. Dr. Deibert is currently accepting new patients.

Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
 (5.3 miles away)
402-559-5600
Languages Spoken:
English, American Sign Language
See accepted insurances
Accepting New Patients
Offers Telehealth

Chad Lagrange is a Urologist practicing medicine in Omaha, Nebraska. Dr. Lagrange is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Lagrange is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew F. Trainer

How do I make an appointment with Dr. Andrew F. Trainer?

You can book an appointment with Dr. Andrew F. Trainer by calling their office at 402-397-7989. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew F. Trainer a top-rated expert for Aquablation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew F. Trainer is classified as an Distinguished expert for Aquablation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew F. Trainer specialize in?

While Dr. Andrew F. Trainer is a Urology, they have specific expertise in Aquablation, Enlarged Prostate (BPH), and Urinary Tract Infection in Children. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Andrew F. Trainer participate in research or clinical trials?

Yes. Dr. Andrew F. Trainer has published 22 articles and abstracts on conditions like Aquablation. You can view a list of Dr. Andrew F. Trainer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew F. Trainer accept my insurance?

Dr. Andrew F. Trainer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 402-397-7989 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trainer's expertise for a condition
ConditionClose
    View All 18 Distinguished Conditions
    View All 33 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile